Tuberculosis - the development of new MDR-TB drugs
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F10%3A00300506" target="_blank" >RIV/00216208:11160/10:00300506 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Tuberculosis - the development of new MDR-TB drugs
Original language description
This book outlines the recent advances in the development of new multidrug-resistant tuberculosis (MDR-TB) drugs. The emergence of resistance to antituberculosis drugs, particularly of MDR-TB and newly XDR-TB has become a major health problem. Chapter IIis an overview of developments in the synthesis of new compounds active on MDR strains of tuberculosis.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NS10367" target="_blank" >NS10367: Evaluation and development of new perspective antimycobacterial drugs and prodrugs active against multidrug resistant strains</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach
Others
Publication year
2010
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Drug-resistant tuberculosis: Causes, diagnosis and treatments
ISBN
978-1-60876-055-8
Number of pages of the result
84
Pages from-to
—
Number of pages of the book
328
Publisher name
Nova Science Publishers
Place of publication
New York
UT code for WoS chapter
—